新医改下民营医药商业企业的未来之路  

The Future of Private Pharmaceutical Commercial Enterprises Under The New Health Care Reform

作　　者：朱竟 景浩[1] 

机构地区：[1]辽宁中医药大学,辽宁沈阳110847

出　　处：《辽宁中医药大学学报》2015年第4期205-206,共2页Journal of Liaoning University of Traditional Chinese Medicine

摘　　要：2009年1月,新一轮医改方案正式出台,新医改方案梳理流通领域的目标已经明确,鼓励支持医药商业龙头企业兼并扩张和战略调整,也将成为今后产业发展的重要特点。新医改背景下,商业的战略扩张行为也将呈现新的特点。民营医药商业企业是我国医药市场的重要组成部分,在改革开放以来,民营医药商业企业不断发展,数量和规模都有了很大的提高。面对新的形势,尤其是在新医改不断深入的情况下,民营医药商业企业如何抓住机遇,实现跨越发展成为社会关注的重点。In January 2009,a new round of healthcare reform formally introduced,the aim of the new healthcare reform carding circulation has been clear,encourage support pharmaceutical commercial enterprises merger expansion and strategic adjustment,also will become the important characteristics of the industry development in the future.Under the background of the reform,the strategic expansion of commercial behavior will also present new characteristics.Private pharmaceutical commercial enterprises is an important part of medical market in our country,in the reform and opening-up,private medicine business enterprise development,the number and size of all had the very big enhancement.Facing the new situation,especially under the condition of the new medical reform deepening,private pharmaceutical commercial enterprises how to seize the opportunity to realize spanning development become the focus of social attention.

关 键 词：民营医药商业企业 新医改 经营策略 

分 类 号：F279.23[经济管理—企业管理]